
Rahul Gosain/LinkedIn
Feb 1, 2025, 18:04
Rahul Gosain: Discussing the recent Sub-cutaneous approval of Nivo with Saby George
Rahul Gosain, Director of Regional Infusion Services at shared a post on LinkedIn:
“Nivo was approved in Melanoma in 2014. A decade later, we’ve 20+ indications. We discuss the recent Sub-cutaneous approval of Nivo with Saby George, from Roswell Park Comprehensive Cancer Center.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 11, 2025, 16:48
Mar 11, 2025, 16:33
Mar 11, 2025, 16:24
Mar 11, 2025, 15:02
Mar 11, 2025, 14:44
Mar 11, 2025, 14:12
Mar 11, 2025, 13:57